Skip to main content

Turning Point Therapeutics, Inc.

TPTXDelisted Aug 17, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001595893

Turning Point Therapeutics, Inc. was delisted on Aug 17, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 209 institutions reported holding it in 13F filings for Q2 2022, worth $3.29B in total; Soros Fund Management was the only superinvestor holding it.

Members of Congress who traded TPTX

No member of Congress has reported a trade in Turning Point Therapeutics, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.